Sanofi Accelerates Flu Vaccine Production for 2025-26 Season, Aligning with FDA-Selected Strains

Sanofi announced the immediate adoption of influenza strains selected by the US Food and Drug Administration (FDA) to advance the manufacturing and ...

March 17, 2025 | Monday | News
Autonomix Advances Sensing and RF Ablation System Toward U.S. Clinical Trials for Pancreatic Cancer Pain

Company successfully meets key milestone with design lock that integrates and finalizes enhancements to its licensed Apex 6 Radiofrequency (“RF&rdq...

March 14, 2025 | Friday | News
Doer Bio Completes Phase 2 Enrollment for DR10624 Tri-Agonist in Severe Hypertriglyceridemia

Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and...

March 10, 2025 | Monday | News
Neurocrine Biosciences Begins Phase 1 Trial for NBI-1140675 in Neurological Disorders

Neurocrine Biosciences, Inc. announced the initiation of a Phase 1 clinical study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynami...

March 06, 2025 | Thursday | News
GHIT Fund Marks Milestone with First Administration of Arpraziquantel to Preschool Children in Uganda

The Global Health Innovative Technology (GHIT) Fund is announcing a significant milestone: the first administration of arpraziquantel to preschool-aged chi...

March 05, 2025 | Wednesday | News
Myriad Genetics Partners with Gabbi to Enhance Breast Cancer Risk Assessment and Specialist Care

Myriad Genetics, Inc., a leader in molecular diagnostics testing and precision medicine, announced a collaboration with Gabbi, a telehealth solution f...

February 28, 2025 | Friday | News
Roche Receives FDA Approval for Evrysdi® Tablet for Spinal Muscular Atrophy

 Roche  announced  that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for an Evrysdi® (risdiplam...

February 13, 2025 | Thursday | News
NeuFit Revolutionizes Neurological Rehabilitation with Innovative NEUBIE Device

 NeuFit is revolutionizing neurological rehabilitation with its innovative approach that integrates advanced diagnostics and therapeutic technolo...

February 06, 2025 | Thursday | News
Zoetis Updates U.S. Label for Librela® (bedinvetmab) Following Post-Approval Experience

Zoetis Inc. announced that it has updated the U.S. label for Librela® (bedinvetmab injection), following its submission of a supplement to the U.S...

February 05, 2025 | Wednesday | News
Vertex Pharmaceuticals Announces FDA Approval of JOURNAVX™ (Suzetrigine) for Acute Pain Treatment

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzet...

January 31, 2025 | Friday | News
Beckman Coulter Life Sciences and Indiana University Secure $2.5M Grant to Boost Leukemia and Lymphoma Testing in Kenya

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, along with the Indiana University School of Medicine, have been a...

January 22, 2025 | Wednesday | News
Trump Administration Takes Bold Step to Withdraw U.S. from World Health Organization

  President Donald J. Trump has signed an executive order initiating the withdrawal of the United States from the World Health Organization (WHO). Th...

January 21, 2025 | Tuesday | News
Sanofi’s Opella Achieves FDA Approval to Initiate OTC Cialis Use Trial

Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical hold on its planned a...

January 21, 2025 | Tuesday | News
PharmAla Biotech Partners with Merhavim Mental Health Centre for Groundbreaking MDMA-Assisted Psychotherapy Trial

PharmAla Biotech Holdings Inc.  a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel deriv...

January 21, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close